PNB-101

N/A

Report date: 2025/01/26 16:52:30
NME

Base Information

Drug NamePNB-101
Drug Alias NamePNB-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholecystokinin antagonistsCholecystokinin B receptor antagonists
TargetsCholecystokinin B receptorCholecystokinin
Therapy Area/IndicationsSmall Cell Lung CarcinomaStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPNB Vesper Life Science Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPNB Vesper Life Science Pvt Ltd
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaStomach Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A